In: Clinical Research in Cardiology, 2015, vol. 104, no. 1, p. 51-58
|
In: Neuroradiology, 2015, vol. 57, no. 10, p. 1045-1054
|
In: Interactive CardioVascular and Thoracic Surgery, 2017, vol. 24, no. 6, p. 967-968
|
In: The International Journal of Cardiovascular Imaging, 2015, vol. 31, no. 5, p. 915-926
|
In: European Radiology, 2015, vol. 25, no. 7, p. 2067-2073
|
In: Child's Nervous System, 2015, vol. 31, no. 3, p. 389-398
|
In: Clinical Research in Cardiology, 2015, vol. 104, no. 2, p. 124-135
|
In: Clinical Research in Cardiology, 2015, vol. 104, no. 8, p. 656-665
|
In: Archives of Gynecology and Obstetrics, 2015, vol. 291, no. 6, p. 1213-1220
|
In: Catheterization and Cardiovascular Interventions, 2019, p. ccd.28376
To evaluate the safety and efficacy outcomes after primary percutaneous coronary intervention (pPCI) with second‐generation Resolute™ zotarolimus‐eluting stent (R‐ ZES) in patients enrolled in the DAPT‐STEMI Trial (NCT01459627).Background: R‐ ZES is one of the most used drug eluting stents worldwide. To date, the safety and efficacy data of this stent in setting of STEMI is...
|